Ultibro Breezhaler (indacaterol/glycopyrronium)
pCPA File Number:
20838
Negotiation Status:
Concluded with an LOI
Indication(s):
Chronic Obstructive Pulmonary Disease
Sponsor/Manufacturer:
Novartis Pharmaceuticals Canada Inc.
CADTH Project Number:
SR0369-000
pCPA Engagement Letter Issued:
Negotiation Process Concluded: